-
Psora 4: Reading Kv1.3 Blockade in T Cells
2026-09-16
Psora 4 is a selective Kv1.3 blocker for connecting membrane excitability with T-cell Ca2+ signaling and effector-memory responses. This article adds a channel-architecture perspective, showing how KCNE4-dependent kinetics should shape assay interpretation and translational decisions.
-
Macrophage Reprogramming in Liver MDB Pathogenesis
2026-09-15
Fang et al. used single-nucleus RNA sequencing and complementary co-culture experiments to resolve macrophage heterogeneity during Mallory-Denk body formation in a DDC-induced mouse model. The study identifies a Gpnmb-high lipid-associated macrophage state and links hepatocyte-derived mitochondrial DNA to NLRP3 inflammasome activation, providing a framework for connecting liver injury, immune-cell remodeling, and protein aggregate pathogenesis.
-
SPOP Molecular Glue Degradation in Melanoma Immunity
2026-09-15
The reference study shows that SPOP promotes melanoma growth by recognizing and degrading STING, while SPOP inhibitors can also redirect the ligase toward CBX4 as molecular glue degraders. This dual activity increases innate immune signaling and improves responses to immune checkpoint blockade and CD19-CAR-T therapy in mouse melanoma models.
-
Foretinib Workflow for Multidimensional Cancer Assays
2026-09-14
Foretinib (GSK1363089) supports more than a single viability endpoint: it can connect Met and VEGFR pathway inhibition with tumor cell growth inhibition, motility, invasion, and metastasis studies. This workflow combines time-resolved viability and cell-death measurements with migration assays to distinguish cytostatic responses from genuine cytotoxicity.
-
Mono-ADP-Ribosylation Marks PARP7 and AHR for Degradation
2026-09-14
The reference study establishes a strategy for revealing normally transient endogenous ADP-ribosylation by blocking ubiquitin-dependent turnover. Its key finding is that DTX2 recognizes ADP-ribosylated PARP7 substrates, including PARP7 and AHR, providing a proteasome-linked mechanism that rapidly limits AHR transcriptional signaling.
-
MK-8745: Aurora A Inhibitor Workflow
2026-09-13
MK-8745 is a potent, selective Aurora A inhibitor for connecting mitotic disruption with G2/M arrest and apoptosis in cancer models. This practical guide covers formulation, cell-based assay design, retinoblastoma translation, xenograft interpretation, and troubleshooting.
-
Liproxstatin-1: A Smarter Ferroptosis Assay
2026-09-12
Liproxstatin-1 is a potent ferroptosis inhibitor for separating lipid peroxidation-driven death from apoptosis and nonspecific oxidative injury. This article develops a sex-aware, mechanism-first assay strategy inspired by a 2025 salivary-gland study.
-
Medial Septum Control of Hippocampal Splitter Cells
2026-09-12
Li et al. show that hippocampal splitter cells multiplex contextual inputs and response information during conditional discrimination learning. The study further identifies medial septum parvalbumin-expressing neurons as a circuit component that selectively supports contextual representations required for accurate associative behavior.
-
Mildronate Lipidoids for Lower-Inflammation mRNA Vaccines
2026-09-11
The 2024 ACS Nano study developed mLNP-69, a lipid nanoparticle containing a low dose of mildronate-derived cationic lipid, to preserve mRNA delivery while reducing local inflammatory effects. In prophylactic and therapeutic B16OVA melanoma models, the formulation supported effective cancer-vaccine activity, providing a preclinical framework for separating delivery performance from lipid-associated inflammation.
-
Biotin-HPDP for Reversible Thiol Labeling
2026-09-11
Biotin-HPDP combines selective cysteine labeling, a cleavable disulfide linkage, and a spacer designed for efficient streptavidin detection. This article shows how to apply it to affinity purification, S-nitrosylation workflows, and mechanistic studies inspired by the HSD17B12–PD-L1 cancer-immunity axis.
-
SD 169: p38 Control for Translational Research
2026-09-10
SD 169 (indole-5-carboxamide) offers a focused way to interrogate p38α and p38β biology across inflammatory, metabolic, and neuroregenerative models. This article connects ATP-competitive kinase inhibition with emerging insights into activation-loop conformation, phosphatase access, and translational assay design.
-
Dlin-MC3-DMA: Practical LNP RNA Delivery
2026-09-10
Dlin-MC3-DMA is an ionizable cationic liposome lipid for building potent siRNA and mRNA nanoparticles, with a well-established rationale for hepatic gene silencing and a growing role in cell-selective immunomodulation. This guide translates its chemistry into formulation, assay, troubleshooting, and machine-learning workflows for RNA delivery research.
-
LINC01977 Super-Enhancer Hijacking in Lung Adenocarcinoma
2026-09-09
Zhang et al. identify LINC01977 as a super-enhancer-hijacked long noncoding RNA that reinforces canonical TGF-β/SMAD3 signaling and promotes malignancy in early-stage lung adenocarcinoma. Their integrated epigenomic, molecular, cellular, and in vivo analyses connect tumor-associated macrophage activity with enhancer regulation, SMAD3 trafficking, CBP/P300 recruitment, and ZEB1 expression.
-
Cy5 NHS ester(Et): Practical Labeling Guide
2026-09-09
Cy5 NHS ester(Et) is an amine-reactive, water-compatible fluorescent reagent for covalently tagging proteins, peptides, and other biomolecules. This guide covers fresh protein fluorescent labeling workflows and explains why ethanol-based protocols and long-term storage of dissolved reagent should be avoided.
-
DHEA Workflows for Ovarian and Neural Research
2026-09-08
Build reproducible DHEA assays for granulosa-cell inflammation, macrophage-conditioned media, neural stem-cell growth, and stress-induced apoptosis. This guide separates DHEA-driven PCOS modeling from direct cell treatment and provides solvent, dosing, endpoint, and troubleshooting strategies.